IWWM-12 2024 | A study investigating treatment prior to autoSCT in POEMS syndrome
Francesco Autore
• 18 Oct 2024
Francesco Autore, MD, PhD, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy, discusses a multi-center study investigating the best treatment strategy before autologous stem cell transplantation (autoSCT) in patients with POEMS syndrome. The findings revealed that patients with comorbidities benefited from cyclophosphamide before autoSCT. This interview took place at the 12th International Workshop on Waldenström’s Macroglobulinemia (IWWM-12) in Prague, Czech Republic.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
